ESTRACE Safety Questions, ESTRACE Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides unique information about ESTRACE. Our extensive database of ESTRACE adverse events and ESTRACE warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Ask Our Health Experts about ESTRACE
ESTRACE Safety Reports
Total ESTRACE reports: 66.ESTRACE FDA safety alerts: No.
Reported deaths: 4 Reported hospitalizations: 3.
Take ESTRACE Side Effects Survey or Share Your ESTRACE Story. ESTRACE Usage.
Showing 1-50 of 66 Next >
Consumer or non-health professional from UNITED STATES reported ESTRACE problem on Apr 06, 2006. Female patient, 75 years of age, weighting 149.9 lb, was diagnosed with osteoporosis and was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: breast cancer. ESTRACE dosage: unknown. During the same period patient was treated with PROVERA, PREMARIN, AYGESTIN, EVISTA, SYNTHROID, ATENOLOL, TIMOPTIC. Patient recovered.ESTRACE problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 06, 2006. Female patient, 58 years of age, was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: breast cancer. ESTRACE dosage: unknown. During the same period patient was treated with PROVERA, PREMARIN, PREMPRO. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ESTRACE problem on July 25, 2007. Female patient, 48 years of age, was diagnosed with menopausal symptoms, depression and was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: breast cancer stage ii. ESTRACE dosage: unknown. During the same period patient was treated with PREMARIN, PROVERA, ESTRATEST, ESTRADERM, ZOLOFT. Patient recovered.
ESTRACE problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 09, 2007. Female patient, 57 years of age, was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: breast cancer. ESTRACE dosage: unknown. During the same period patient was treated with PROVERA, PREMPRO, MEDROXYPROGESTERONE ACETATE. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ESTRACE problem on Aug 09, 2007. Female patient, 56 years of age, was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: breast cancer. ESTRACE dosage: unknown. During the same period patient was treated with PREMARIN, AYGESTIN, PROVERA. Patient recovered.
ESTRACE problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 11, 2007. Female patient was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: breast cancer. ESTRACE dosage: unknown. During the same period patient was treated with PREMPHASE, PREMARIN, PROVERA. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ESTRACE problem on July 25, 2006. Female patient, 59 years of age, was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: fungal infection. ESTRACE dosage: unknown. Patient recovered.
ESTRACE problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 04, 2006. Female patient, 65 years of age, was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: breast cancer. ESTRACE dosage: unknown. During the same period patient was treated with PROVERA, PREMPRO. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ESTRACE problem on Dec 14, 2006. Female patient, 51 years of age, was diagnosed with menopausal symptoms and was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: breast cancer. ESTRACE dosage: unknown. During the same period patient was treated with ESTRADIOL, PROVERA, MEDROXYPROGESTERONE, CYCRIN. Patient recovered.
ESTRACE problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 03, 2007. Female patient, 57 years of age, was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: breast cancer. ESTRACE dosage: unknown. During the same period patient was treated with PROVERA, PROMETRIUM, ESTRADIOL, MEDROXYPROGESTERONE. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ESTRACE problem on Jan 03, 2007. Female patient, 61 years of age, was diagnosed with menopausal symptoms and was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: breast cancer. ESTRACE dosage: unknown. During the same period patient was treated with PREMARIN, PROVERA. Patient died on 04/30/2005.
ESTRACE problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 20, 2007. Female patient, 53 years of age, was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: coronary artery disease. ESTRACE dosage: unknown. Patient recovered.
Consumer or non-health professional from UNITED STATES reported ESTRACE problem on Aug 07, 2007. Female patient, 59 years of age, was diagnosed with menopausal symptoms and was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: blood pressure decreased, carcinoid syndrome, diarrhoea, headache, hyperhidrosis, hypoaesthesia, palpitations, paraesthesia. ESTRACE dosage: 2 MG, QHS, ORAL. During the same period patient was treated with LEVOTHROID. Patient recovered.
ESTRACE problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 17, 2007. Female patient, 67 years of age, weighting 115.0 lb, was diagnosed with menopausal symptoms and was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: biopsy breast, breast cancer in situ, epistaxis, lymphoedema, massage, mastectomy, nasal polyps, oestrogen receptor assay positive, osteoporosis. ESTRACE dosage: unknown. During the same period patient was treated with PROVERA, PREMARIN, ESTRADERM, ESTRATEST, PROVENTIL, BECLOVENT, VANCENASE. Patient recovered.
Health Professional from UNITED STATES reported ESTRACE problem on Aug 29, 2007. Female patient, 53 years of age, was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: breast cancer, depression, somatisation disorder. ESTRACE dosage: unknown. During the same period patient was treated with PREMPRO, PREMARIN, PROVERA, ESTROGEN, MEDROXYPROGESTERONE ACETATE, PRAMOSONE, ALPRAZOLAM, DONNATAL. Patient recovered.
ESTRACE problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 04, 2007. Female patient, 69 years of age, was diagnosed with atrophic vulvovaginitis, pain and was treated with ESTRACE. After drug was administered, patient experienced the following problems/side effects: deep vein thrombosis, stomatitis. ESTRACE dosage: unknown. During the same period patient was treated with COUMADIN, ASPIRIN, AMANTADINE, LIPITOR, HYDROCHLOROTHIAZIDE, PREVACID. Patient recovered.
Showing 1-50 of 66 Next >